Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting of endoplasmic reticulum dysfunction and protein folding stress to treat neurological conditions

Targeting of endoplasmic reticulum dysfunction and protein folding stress to treat neurological conditions

US Patent 12157728 · Granted Dec 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2025
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2025
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2023
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2023
Copper complexes for treatment of neurodegenerative disorders2023
Copper complexes for treatment of neurodegenerative disorders2023
Anti-CD40L antibodies2021
Anti-CD40L antibodies2021
Methods of treating a CD40L associated disease or disorder by administering anti2020
Methods of treating a CD40L associated disease or disorder by administering anti2020